NEWS

On February 3, 2026, Ruchuan Gu successfully defended his half-time PhD work, an important component of The Bridge research program focused on developing cell-based therapies for injured donor organs. His work represents a significant contribution to the center’s regenerative medicine efforts, and we extend sincere thanks to all collaborators and supervisors involved in this achievement. Runchuan Gu

On January 29, 2026, Society of Thoracic Surgeons (STS) hosted a comprehensive lung transplantation education day in conjunction in New Orleans. The full-day program covered the entire transplant pathway, from donor management and organ preservation to recipient care and post-transplant outcomes. The session attracted a large international audience and fostered active discussions on the importance of centralized EVLP services and strategies to maximize the utilization of dono

In January 2026, The Bridge Lund for Life  successfully evaluated four donor lungs for clinical transplantation, all of which were ultimately transplanted. Achieving this volume within a single month represents a major milestone for the center. This success reflects close collaboration across Sweden and Denmark and the dedicated efforts of multidisciplinary teams, with key contributions from Hasse Sorensen, Michael Perch and Sandra Lindstedt. The achievement underscores the i

In the first week of December 2025, the European Respiratory Society visited The Bridge - Lungs for Life  for an intensive two-day filming project. The ERS team documented the full scope of our organization, including preclinical development, cell therapy programs in Lund, educational initiatives, and the clinical lung evaluation facilities in Copenhagen at Rigshospitalet. Through extensive interviews and on-site filming, the ERS captured the complete translational pipeline—f

During autumn 2025, The Bridge - Lungs for Life  conducted a series of intensive joint preclinical development weeks focused on advancing cell-based therapies for injured donor lungs. Multidisciplinary teams worked closely together to evaluate therapeutic strategies aimed at restoring lung function and improving transplantability. These collaborative sessions resulted in encouraging outcomes, demonstrating improved lung parameters and reinforcing the potential of cell therapy

On 22–23 October 2025, representatives from The Bridge – Lungs for Life participated in the XVIVO Masterclass on Lung Transplantation, held in Malmö, Sweden. The event gathered leading clinicians, researchers, and industry partners from across Europe, Switzerland, the United Kingdom, and the United States to discuss recent advances in lung preservation, ex vivo lung perfusion (EVLP), and regenerative therapies.

The European society of heart and lung transplantation (ESHLT) is a leading organisation providing education for medical professionals involved in heart and lung transplantation. Representatives from The Bridge - including Hasse Sorensen , Michael Perch and Franziska Olm —presented at the meeting. Their talks highlighted the Bridge model, advances in cell-based therapies, and the development of a centralized EVLP platform. The presentations emphasized how integrated infrastr